BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 26025724)

  • 41. Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/ cardiomyopathy: a multisoftware feasibility and clinical implementation study.
    Bourfiss M; Vigneault DM; Aliyari Ghasebeh M; Murray B; James CA; Tichnell C; Mohamed Hoesein FA; Zimmerman SL; Kamel IR; Calkins H; Tandri H; Velthuis BK; Bluemke DA; Te Riele ASJM
    J Cardiovasc Magn Reson; 2017 Sep; 19(1):66. PubMed ID: 28863780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial form of arrhythmogenic right ventricular cardiomyopathy.
    Włodarska EK; Konka M; Kepski R; Zaleska T; Płoski R; Ruzyłło W; Janion M; Jaworska K; Rydlewska-Sadowska W; Hoffman P
    Kardiol Pol; 2004 Jan; 60(1):1-14. PubMed ID: 15004627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Iacoviello M; Forleo C; Puzzovivo A; Nalin I; Guida P; Anaclerio M; Marangelli V; Sorrentino S; Monitillo F; Ciccone MM; Favale S
    Eur J Echocardiogr; 2011 Oct; 12(10):773-81. PubMed ID: 21865227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.
    Philips B; Madhavan S; James CA; te Riele AS; Murray B; Tichnell C; Bhonsale A; Nazarian S; Judge DP; Calkins H; Tandri H; Cheng A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):230-6. PubMed ID: 24585727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy - a cardiac magnetic resonance imaging study.
    El Ghannudi S; Nghiem A; Germain P; Jeung MY; Gangi A; Roy C
    Clin Med Insights Cardiol; 2014; 8(Suppl 4):27-36. PubMed ID: 25788837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of speckle tracking echocardiography imaging in patients with asymptomatic and symptomatic arrhythmogenic right ventricular cardiomyopathy.
    Alizade E; Yesin M; Tabakci MM; Avci A; Bulut M; Acar G; Şimşek Z; Izci S; Barutçu S; Pala S
    Echocardiography; 2016 Nov; 33(11):1683-1688. PubMed ID: 27599902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrhythmogenic right ventricular dysplasia.
    Calkins H
    Trans Am Clin Climatol Assoc; 2008; 119():273-86; discussion 287-8. PubMed ID: 18596851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia with high defibrillation threshold requiring subcutaneous shocking coil implantation.
    Mohsen A; Panday M; Wetherold S; Jimenez A
    Heart Lung Circ; 2012 Jan; 21(1):46-9. PubMed ID: 21982156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis.
    Vives-Gilabert Y; Sanz-Sánchez J; Molina P; Cebrián A; Igual B; Calvillo-Batllés P; Domingo D; Millet J; Martínez-Dolz L; Castells F; Zorio E
    Int J Cardiol; 2019 Jan; 274():237-244. PubMed ID: 30228020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of right and left ventricular function using speckle tracking echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy and their first degree relatives.
    Aneq MÅ; Engvall J; Brudin L; Nylander E
    Cardiovasc Ultrasound; 2012 Sep; 10():37. PubMed ID: 22992412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging.
    Luijkx T; Velthuis BK; Prakken NH; Cox MG; Bots ML; Mali WP; Hauer RN; Cramer MJ
    Eur J Prev Cardiol; 2012 Aug; 19(4):885-91. PubMed ID: 21690305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
    Piccini JP; Dalal D; Roguin A; Bomma C; Cheng A; Prakasa K; Dong J; Tichnell C; James C; Russell S; Crosson J; Berger RD; Marine JE; Tomaselli G; Calkins H
    Heart Rhythm; 2005 Nov; 2(11):1188-94. PubMed ID: 16253908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study.
    Dalal D; Tandri H; Judge DP; Amat N; Macedo R; Jain R; Tichnell C; Daly A; James C; Russell SD; Abraham T; Bluemke DA; Calkins H
    J Am Coll Cardiol; 2009 Apr; 53(15):1289-99. PubMed ID: 19358943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Bomma C; Rutberg J; Tandri H; Nasir K; Roguin A; Tichnell C; Rodriguez R; James C; Kasper E; Spevak P; Bluemke DA; Calkins H
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):300-6. PubMed ID: 15030420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and prognostic value of concealed structural abnormalities in patients with apparently idiopathic ventricular arrhythmias of left versus right ventricular origin: a magnetic resonance imaging study.
    Nucifora G; Muser D; Masci PG; Barison A; Rebellato L; Piccoli G; Daleffe E; Toniolo M; Zanuttini D; Facchin D; Lombardi M; Proclemer A
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):456-62. PubMed ID: 24771543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study).
    Morel E; Manati AW; Nony P; Maucort-Boulch D; Bessière F; Cai X; Besseyre des Horts T; Janin A; Moreau A; Chevalier P
    Clin Cardiol; 2018 Mar; 41(3):300-306. PubMed ID: 29574980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity.
    te Riele AS; James CA; Bhonsale A; Groeneweg JA; Camm CF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; Judge DP; Hauer RN; Tandri H; Calkins H
    Heart Rhythm; 2013 Oct; 10(10):1484-91. PubMed ID: 23816439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia.
    Saguner AM; Ganahl S; Baldinger SH; Kraus A; Medeiros-Domingo A; Nordbeck S; Saguner AR; Mueller-Burri AS; Haegeli LM; Wolber T; Steffel J; Krasniqi N; Delacrétaz E; Lüscher TF; Held L; Brunckhorst CB; Duru F
    Am J Cardiol; 2014 May; 113(10):1728-34. PubMed ID: 24792740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.